A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression
The DOI matches its Crossref record.
Abstract
BACKGROUND: More treatment options for bipolar depression are needed. Currently available antidepressants may increase the risk of mania and rapid cycling, and mood stabilizers appear to be less effective in treating depression than mania. Preliminary data suggest that lamotrigine, an established antiepileptic drug, may be effective for both the depression and mania associated with bipolar disorder. This is the first controlled multicenter study evaluating lamotrigine monotherapy in the treatment of bipolar I depression. METHODS: Outpatients with bipolar I disorder experiencing a major depressive episode (DSM-IV, N = 195) received lamotrigine (50 or 200 mg/day) or placebo as monotherapy for 7 weeks. Psychiatric evaluations, including the Hamilton Rating Scale for Depression (HAM-D), the Montgomery-Asberg Depression Rating Scale (MADRS), Mania Rating Scale, and the Clinical Global Impressions scale for Severity (CGI-S) and Improvement (CGI-I) were completed at each weekly visit. RESULTS: Lamotrigine 200 mg/day demonstrated significant antidepressant efficacy on the 17-item HAM-D, HAM-D Item 1, MADRS, CGI-S, and CGI-I compared with placebo. Improvements were seen as early as week 3. Lamotrigine 50 mg/day also demonstrated efficacy compared with placebo on several measures. The proportions of patients exhibiting a response on CGI-I were 51%, 41%, and 26% for lamotrigine 200 mg/day, lamotrigine 50 mg/day, and placebo groups, respectively. Adverse events and other safety results were similar across treatment groups, except for a higher rate of headache in the lamotrigine groups. CONCLUSION: Lamotrigine monotherapy is an effective and well-tolerated treatment for bipolar depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while clinical experience and the results of many studies suggest that response to mood stabilizers and antipsychotics is similar in BDII and BDI, there are enough exceptions to suggest this should not be taken for granted.248, 405, 431”
Citations
Cites
Still being checked.
Cited by
Items 501–600 of 1,000
Presentations of depression in bipolar illness
Post, R. M., Denicoff, K. D., Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T. M., Keck, P. E., McElroy, S. L., Kupka, R., Nolen, W. A., et al. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00039-7 · Cited by 19
Mitchell, P. B. (1999) · Australian & New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.1999.00672.x · Cited by 15
Bipolar depression: the role of atypical antipsychotics
Post, R. M., & Calabrese, J. R. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.6.s27 · Cited by 14
Self-citationLamotrigine and Rash: Scratching Beneath the Surface
Labiner, D. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1109 · Cited by 14
Lamotrigine: A Review of Clinical Studies in Bipolar Disorders
Zerjav-Lacombe, S., & Tabarsi, E. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104600403 · Cited by 14
Polypharmacy of Bipolar Disorder
Ghaemi, S. N., & Ko, J. Y. (2002) · CRC Press eBooks · doi:10.1201/b15278-7 · Cited by 14
Olanzapine/fluoxetine combination for bipolar depression
Shelton, R. C. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.1.33 · Cited by 14
Bipolar depression: trial-based insights to guide patient care
Kemp, D. E., Muzina, D. J., Mclntyre, R. S., & Calabrese, J. R. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.2/dekemp · Cited by 15
Self-citationLessons from STEP-BD for the treatment of bipolar depression
Nierenberg, A. A. (2009) · Depression and Anxiety · doi:10.1002/da.20547 · Cited by 13
Lamotrigine in the treatment of recurrent brief depression
Ravindran, L. N., & Ravindran, A. V. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328013f89d · Cited by 13
Safety and tolerability of anticonvulsant medication in bipolar disorder
Pichler, E. M., Hattwich, G., Grunze, H., & Muehlbacher, M. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1088001 · Cited by 15
Born, C., Bernhard, B., Dittmann, S., Seemüller, F., & Grunze, H. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.07.020 · Cited by 15
Treatment-resistant bipolar disorder
Gitlin, M. J. (2001) · Bulletin of the Menninger Clinic · doi:10.1521/bumc.65.1.26.18709 · Cited by 13
Ketter, T. A., & Drevets, W. C. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00043-9 · Cited by 15
Lamotrigine for the Treatment of Bipolar Disorder
Engle, P. M., & Heck, A. M. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19128 · Cited by 13
New Designs for Studies of the Prophylaxis of Bipolar Disorder
Post, R. M., Keck, P. E., & Rush, A. J. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00001 · Cited by 13
Safety and Efficacy of Lamotrigine in Older Adults with Epilepsy and Co-Morbid Depressive Symptoms
Schiller, Y., & Krivoy, N. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s2165 · Cited by 12
A narrative review on invasive brain stimulation for treatment-resistant depression
Dandekar, M. P., Díaz, A. P., Rahman, Z., da Silva, R. H., Nahas, Z. H., Aaronson, S. T., Selvaraj, S., Fenoy, A. J., Sanches, M., Soares, J. C., et al. (2022) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2021-1874 · Cited by 13
Effect of lamotrigine on plasma GABA levels in healthy humans
Shiah, I., Yatham, L. N., Gau, Y.-C., & Baker, G. B. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00028-9 · Cited by 12
The role of quetiapine extended release in the treatment of bipolar depression
Cristancho, M., & Thase, M. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0067-9 · Cited by 14
Bowen, R., Balbuena, L., & Baetz, M. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000164 · Cited by 12
Systematic Review of Recent Guidelines for Pharmacological Treatments of Bipolar Disorders in Adults
Hammett, S., & Youssef, N. A. (2017) · Annals of Clinical Psychiatry · doi:10.1177/104012371702900409 · Cited by 14
Bourin, M., Chenu, F., & Hascoët, M. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.07.030 · Cited by 12
Transtornos de humor refratários a tratamento
Machado‐Vieira, R., & Soares, J. C. (2007) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462006005000058 · Cited by 18
Bipolar Spectrum Disorder: Differential Diagnosis and Treatment
Muzina, D. J. (2007) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2007.06.001 · Cited by 13
Diagnosis and management of patients with bipolar disorder in primary care.
Berk, M., Dodd, S., Berk, L., & Opie, J. (2005) · Europe PMC (PubMed Central) · Cited by 12
Neue Erkenntnisse zur Pathogenese und Pathophysiologie der Depression
Schüle, C., Baghai, T. C., & Rupprecht, R. (2007) · Der Nervenarzt · doi:10.1007/s00115-007-2370-5 · Cited by 22
Southam, E., Pereira, R., Stratton, S. C., Sargent, R., Ford, A. J., Butterfield, L. J., Wheable, J. D., Beckett, S. R. G., Roe, C., Marsden, C. A., et al. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.07.005 · Cited by 12
Tringali, G., Aubry, J. M., Navarra, P., & Pozzoli, G. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0539-4 · Cited by 13
Anticonvulsants in Bipolar Disorder
Singh, V. K., Muzina, D. J., & Calabrese, J. R. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.02.004 · Cited by 12
Self-citationAntidepressant treatment-associated behavioural expression of hypomania: a case series
Ramasubbu, R. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.06.015 · Cited by 12
Assessment of treatment response in mania: commentary and new findings
Baldessarini, R. J. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00020.x · Cited by 12
Cai, L., Chen, G., Yang, H., & Bai, Y. (2023) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000449 · Cited by 11
“In published fixed-dose studies, the lamotrigine 200 mg/day group (Calabrese et al., 1999) showed a significantly increased efficacy with a moderate effect size relative to placebo (Table 1).”
BackgroundResultInfluentialAdjunctive use of modafinil in bipolar patients: just another stimulant or not?
Shelton, R. C., & Reddy, R. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0082-6 · Cited by 11
Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines
Jeong, J., Lee, J. G., Kim, M.-D., Sohn, I., Shim, S.-H., Wang, H. R., Woo, Y. S., Jon, D., Seo, J. S., Shin, Y.-C., et al. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s86552 · Cited by 12
Sajatovic, M., Thompson, Nanry, Edwards, & Manjunath (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s40271 · Cited by 11
Zimmerman, M. A., Holst, C. G., Clark, H., Multach, M. D., Walsh, E. K., Rosenstein, L. K., & Gazarian, D. (2016) · CNS Drugs · doi:10.1007/s40263-016-0381-0 · Cited by 11
Quiroz, J. A., & Manji, H. K. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.1/jquiroz · Cited by 12
The treatment of bipolar mixed states
Cookson, J., & Ghalib, S. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544019.016 · Cited by 11
Mood Disorders in Family Practice: Beyond Unipolarity to Bipolarity
Manning, J. S., Ahmed, S., McGuire, H. C., & Hay, D. P. (2002) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v04n0405 · Cited by 16
Lamotrigine-associated reversible severe hepatitis: A case report
Ngo, A. S.-Y., Tai, W. W., & Olson, K. R. (2008) · Journal of Medical Toxicology · doi:10.1007/bf03161210 · Cited by 12
Is Lithium Still the Maintenance Treatment of Choice for Bipolar Disorder?
Silverstone, T. (2000) · CNS Drugs · doi:10.2165/00023210-200014020-00001 · Cited by 11
The use of newer anticonvulsants in neuropsychiatric disorders
Kim, E. (2002) · Current Psychiatry Reports · doi:10.1007/s11920-002-0080-z · Cited by 11
Use of Antiepileptic Medications In Nursing Homes
Garrard, J. M., Harms, S. L., Eberly, L. E., & Leppik, I. E. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)81010-x · Cited by 11
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder
Gnanadesikan, M., Freeman, M. P., & Gelenberg, A. J. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00032.x · Cited by 12
Maintenance treatment in bipolar disorder: a focus on aripiprazole
McIntyre, R. S., Woldeyohannes, H. O., Yasgur, B. S., Soczynska, J. K., Miranda, A., & Konarski, J. Z. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.8.919 · Cited by 12
Rapid cycling bipolar disease: New concepts and treatments
Dubovsky, S. L. (2001) · Current Psychiatry Reports · doi:10.1007/s11920-001-0038-6 · Cited by 11
Mechanisms of Action of Medicines for Schizophrenia and Bipolar Illness: Status and Limitations
Scolnick, E. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.022 · Cited by 14
Successful rechallenge with slowly titrated lamotrigine after rash
Manfredi, G., Pacchiarotti, I., Kotzalidis, G. D., Ruberto, A., Girardi, P., & Tatarelli, R. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00106.x · Cited by 11
Recent placebo-controlled acute trials in bipolar depression: focus on methodology
Muzina, D. J., & Calabrese, J. R. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003559 · Cited by 13
Self-citationThe Nurse’s Role in the Assessment and Treatment of Bipolar Disorder
Tugrul, K. C. (2003) · Journal of the American Psychiatric Nurses Association · doi:10.1016/j.japna.2003.10.005 · Cited by 13
Developments in mood stabilisers
Ferrier, I. N. (2001) · British Medical Bulletin · doi:10.1093/bmb/57.1.179 · Cited by 11
Is there a lamotrigine withdrawal syndrome?
Gelisse, P., Kissani, N., Crespel, A., Jafari, H., & Baldy-Moulinier, M. (2002) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2002.1c220.x · Cited by 10
Bajbouj, M., Luborzewski, A., Danker‐Hopfe, H., & Lang, U. E. (2005) · Journal of Ect · doi:10.1097/01.yct.0000180039.12176.9c · Cited by 10
Li, Y., Zhang, F., Xu, Y., Hu, J., & Li, H. (2018) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.449 · Cited by 10
Edenfield, T. M. (2007) · DigitalCommons (California Polytechnic State University) · Cited by 15
The effect of lamotrigine on platelet serotonin concentration in patients with bipolar depression
Šagud, M., Pivac, N., Mustapić, M., Erjavec, G. N., Peleš, A. M., Kramarić, M., Jakovljević, M., & Mück‐Šeler, D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1074-2 · Cited by 10
First International Exchange on Bipolar Disorder
Montgomery, S., & Keck, P. E. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00181-6 · Cited by 11
Barry, J. J., Lembke, A., & Bullock, K. D. (2004) · Clinical EEG and Neuroscience · doi:10.1177/155005940403500107 · Cited by 11
Differing psychotropic profiles of the anticonvulsants in bipolar and other psychiatric disorders
Post, R. M. (2004) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2004.06.003 · Cited by 14
Response to placebo among bipolar I disorder patients experiencing their first manic episode
Chengappa, K. R., Tohen, M. F., Levine, J., Jacobs, T. G., Thase, M. E., Sanger, T. M., & Kupfer, D. J. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020407.x · Cited by 12
Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders
Janenawasin, S., Wang, P. W., Lembke, A., Schumacher, M. R., Das, B., Santosa, C. M., Mongkolcheep, J., & Ketter, T. A. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01210.x · Cited by 10
Use of Antiepileptics in Traumatic Brain Injury: A Review for Psychiatrists
Kennedy, R., Burnett, D. M., & Greenwald, B. D. (2001) · Annals of Clinical Psychiatry · doi:10.3109/10401230109148964 · Cited by 10
Attention-Deficit/Hyperactivity Disorder, Binge Eating, and Obesity
Cortese, S., Isnard, P., Bernardina, B. D., & Mouren, M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0624h · Cited by 10
Korean Medication Algorithm for Bipolar Disorder 2010: Introduction
Minkyungjoon, Bahk, W., Yoon, B.-H., Kim, W. K., 김병수, Lee, J. G., Joo, Y. H., Seo, J., Lee, E. M., Ahn, Y.-M., et al. (2011) · 대한정신약물학회지 · Cited by 10
Treatment of bipolar depression
Musetti, L., Grande, C. D., Marazziti, D., & Dell’Osso, L. (2013) · CNS Spectrums · doi:10.1017/s1092852912001009 · Cited by 10
Woo, Y. S., Bahk, W., Jon, D., Chung, S., Lee, S., Ahn, Y. M., Pae, C., Cho, H. S., Kim, J., Hwang, T., et al. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02026.x · Cited by 9
The return of fixed combinations in psychiatry: fluoxetine and olanzapine combination
Shelton, R. C. (2006) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.2006.2.2.187 · Cited by 11
New Uses for Lithium and Anticonvulsants
Salzman, C. (2003) · Harvard Review of Psychiatry · doi:10.1080/hrp.11.5.230.244 · Cited by 10
Lamotrigine for the treatment of bipolar spectrum disorder: a chart review
Montes, J. M. G., Sáiz-Ruiz, J., Lahera, G., & Asiel, Á. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.11.012 · Cited by 10
Treatment advances in bipolar disorder—making up for lost time
Keck, P. E. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00990-2 · Cited by 9
Safety Considerations in Pharmacotherapy of Bipolar Disorder
Masand, P. S., Fazal, F. S., & Patkar, A. A. (2004) · CNS Spectrums · doi:10.1017/s1092852900028856 · Cited by 9
What Drugs Are Best for Bipolar Depression?
Baldassano, C. F., Datto, S. M., Littman, L., & Lipari, M. A. (2003) · Annals of Clinical Psychiatry · doi:10.1023/b:acli.0000008176.32677.32 · Cited by 9
New Perspectives in the Acute Treatment of Bipolar Depression
Grunze, H., Schlösser, S., & Walden, J. (2000) · The World Journal of Biological Psychiatry · doi:10.3109/15622970009150580 · Cited by 9
Scandinavica, A. P., & Calabrese, J. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00534.x · Cited by 9
Self-citationAlgorithms for the Pharmacotherapy of Acute Depression in Patients With Bipolar Disorder
Dantzler, A., & Osser, D. N. (1999) · Psychiatric Annals · doi:10.3928/0048-5713-19990501-09 · Cited by 9
“A two‐illness model of bipolar disorder” – by RT Joffe, LT Young, and GM MacQueen: a commentary
Swann, A. C. (1999) · Bipolar Disorders · doi:10.1034/j.1399-5618.1999.10110.x · Cited by 9
Fountoulakis, K. Ν. (2010) · Annals of General Psychiatry · doi:10.1186/1744-859x-9-3 · Cited by 10
Kriner, P., Brieger, P., Pogarell, O. M., Schüle, C., Mußmann, L., Korbmacher, J. M., & Seemüller, F. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1425549 · Cited by 8
Emerging novel treatments for severe mood disorders involving cellular plasticity cascades
Machado‐Vieira, R., Zarate, C. A., & Manji, H. K. (2006) · Current Psychosis & Therapeutics Reports · doi:10.1007/bf02629394 · Cited by 8
Köhler, S., Bauer, M., & Bschor, T. (2013) · Der Nervenarzt · doi:10.1007/s00115-013-3919-0 · Cited by 8
Assion, H.-J., Schweppe, A., Reinbold, H., & Frommberger, U. (2018) · Der Nervenarzt · doi:10.1007/s00115-018-0507-3 · Cited by 8
Divalproex sodium in the treatment of adults with bipolar disorder
Davis, L. L., Williams, R. B., & Cates, M. E. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.3.349 · Cited by 11
Pharmacologic treatment of geriatric mania
McDonald, W. M., & Wermager, J. (2002) · Current Psychiatry Reports · doi:10.1007/s11920-002-0012-y · Cited by 8
Li, X., Yu, T., Huang, X., Cao, Y., Li, X., Liu, B., Yang, F., Li, W., Zhao, X., Feng, G., et al. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000119 · Cited by 8
Antidepressants have complex associations with longitudinal depressive burden in bipolar disorder
Hooshmand, F., Do, D., Shah, S., Gershon, A., Park, D. Y., Yuen, L. D., Dell’Osso, B. M., Wang, P. W., Miller, S., & Ketter, T. A. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.074 · Cited by 9
A 25-Year-Old Woman With Bipolar Disorder
Sachs, G. S. (2001) · JAMA · doi:10.1001/jama.285.4.454 · Cited by 8
Self-citationMood Changes in Epilepsy Patients Treated with Vagus Nerve Stimulation
Harden, C. L. (2001) · Epilepsy & Behavior · doi:10.1006/ebeh.2001.0203 · Cited by 8
Mood-Stabilizing Properties of Lamotrigine: A Review of Data from Controlled Clinical Trials
Leadbetter, R. A., Messenheimer, J. A., Bentley, B., Greene, P., Huffman, R., & Spaulding, T. C. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20021201-12 · Cited by 8
Antiepileptic Drugs in the 21st Century
Bazil, C. W. (2001) · CNS Spectrums · doi:10.1017/s1092852900001504 · Cited by 8
Current concepts in rapid cycling bipolar disorder
Shelton, M. D., & Calabrese, J. R. (2000) · Current Psychiatry Reports · doi:10.1007/s11920-000-0073-8 · Cited by 10
Self-citationSchizophrenia Symptoms Remain Stable During Decreases From 2 Antipsychotics to Aripiprazole
Salzman, C., Rosenberg, J., & Feldman, J. J. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0624a · Cited by 7
Sunder, T. R., McKee, J. R., Hammer, A. E., & Vuong, A. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x96281 · Cited by 7
Indução de mania durante o tratamento com antidepressivos no transtorno bipolar
Tamada, R. S., & Lafer, B. (2003) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462003000300010 · Cited by 12
D’Souza, U. M., Powell‐Smith, G., Haddley, K., Powell, T. R., Bubb, V. J., Price, T., McGuffin, P., Quinn, J. P., & FARMER, A. E. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32178 · Cited by 7
Lamotrigine Combined with Divalproex or Lithium for Bipolar Disorder:A Case Series
Redmond, J. R., Jamison, K. L., & Bowden, C. L. (2006) · CNS Spectrums · doi:10.1017/s1092852900015091 · Cited by 7
Self-citationPost, R. M. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00037-3 · Cited by 7
Treatment-Resistant Bipolar Disorder: A Comparison of Rapid Cyclers and Nonrapid Cyclers
Vo, D., & Dünner, D. L. (2003) · CNS Spectrums · doi:10.1017/s1092852900028716 · Cited by 8
Kikkawa, A., Kitamura, Y., Aiba, T., Hiraki, K., & Sendo, T. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00725 · Cited by 7
Depression mood stabilisation: novel concepts and clinical management
Calabrese, J. R. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.03.002 · Cited by 7
Self-citation
Metadata
- Authors
- Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group
- Affiliations
- Case Western Reserve University (US)
- GlaxoSmithKline (United Kingdom) (GB)
- ORCID
- Calabrese, Joseph R.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1999-02-15
- Volume
- 60
- Issue
- 2
- Pages
- 79-88
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2058120764
- Cited by
- 1,054
- References
- 0
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 15 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 162 · 2019: 10 · 2018: 13 · 2017: 13 · 2016: 13 · 2015: 18 · 2014: 23 · 2013: 24 · 2012: 34
- FWCI
- 47.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- lamotrigine, bipolar I depression, bipolar disorder, antidepressant monotherapy, antiepileptic drugs, major depressive episode, treatment response, adverse events, headache, drug tolerability
- MeSH terms
- Lamotrigine, Adult, Aged, Ambulatory Care, Anticonvulsants, Bipolar Disorder, Depressive Disorder, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Patient Compliance, Placebos, Psychiatric Status Rating Scales, Severity of Illness Index, Triazines, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.